Abstract. Spinal fluid lymphocytes from multiple sclerosis (MS) patients and controls were stimulated with either autologous non-T cells or with allogeneic non-T cells followed by stimulation with autologous non-T lymphocytes. Cells responding to these stimuli were cloned and their proliferative responses to autologous and allogeneic MS and normal non-T cells were measured. Large numbers of clones with specific patterns of reaction to both autologous and allogeneic cells were obtained from lymphocytes in MS cerebrospinal fluid (CSF), but only occasionally from cells in control CSF. Patterns of responses among clones from a particular CSF were similar and often identical, which suggested that cells in MS CSF were relatively restricted in their specificities. Surface antigen phenotyping of the clones showed them to be predominantly OKT4+, with 13% OKT8+ and 11% OKT4+8+. Peripheral T cells that were stimulated and cultured in parallel with CSF cells were different in that they usually did not give rise to as many clones nor were their patterns of response similar. Many CSF clones were heteroclitic, that is they responded to particular allogeneic cells but not autologous cells. Lymphocytes in MS CSF thus appear to represent a selected population of cells with a high frequency of responsiveness to autologous and allogeneic antigens. Such responses may be evidence for immune regulation within the central nervous system or could represent responses to altered-self antigens.
Introduction
Multiple sclerosis (MS)' may be an autoimmune disease that results from or is associated with a persistent viral infection of the central nervous system (CNS) (1) (2) (3) (4) . Large numbers of lymphocytes are present within the CNS of patients, particularly in perivenular regions adjacent to areas of demyelination (5, 6) . In addition, during acute exacerbations or with chronic active progression of the disease, a mononuclear cell pleocytosis is observed in the cerebrospinal fluid (CSF) (7, 8) . The antigen(s) responsible for evoking these cellular responses is not known.
Several laboratories have characterized the lymphocytes found in the CSF of MS patients. Kam-Hansen et al. (9) and Naronha et al. (10) demonstrated that most of the cells in MS CSF were T cells and many were "activated" or in a state of DNA synthesis. Cashman et al. (11) and Hauser et al. (12) quantitated subpopulations of T lymphocytes in MS CSF and peripheral blood and correlated these with changes in clinical status. Merrill et al. (13) demonstrated loss of natural killer cell activity in MS CSF, which suggests that MS CSF lymphocytes may be different from cells seen in control CSF. Other laboratories have noted the presence of MS spinal fluid lymphocytes that are reactive to myelin basic protein (14) , measles antigen (15-), mitogens (16) , and alloantigens (17) . Thus, there are large numbers of immunocompetent cells in the CSF of MS patients, and these cells may be different than cells seen in the CSF of patients with other neurologic diseases.
Our experiments were designed to further investigate the specificity of lymphocytes in the CSF of MS patients. Our experiments were based on the following observations and hypotheses:
(a) Autologous major histocompatibility complex (MHC) antigens may be important in the pathogenesis of MS. Im- munologic recognition of viral antigens is restricted by autologous MHC antigens (18) . If the virus(es) associated with MS is a common one, and we feel, based upon other virally associated immune diseases, that this is most likely, then autologous antigens in MS patients may determine the development of the disease. In other words, the configuration of autologous antigens in MS may be such that their association with particular viral antigens results in an immune response crossreactive with CNS antigens. In support of this hypothesis are the observations that certain HLA phenotypes are associated with the illness (19) . These genetic markers are not unique to MS patients, which suggests that they are linked to, but are not themselves, the MS susceptibility gene products.
In addition, cells responding to autologous antigens in an autologous mixed lymphocyte reaction (MLR) possess regulatory activity, demonstrating both helper (20) and suppressor function (21). The autologous MLR is increased in the peripheral blood of MS patients (22) , and the presence of an autologous reaction in the CNS of patients with MS may be an important in situ regulatory mechanism.
(b) It has been well demonstrated in the mouse (23, 24 ) and in man (25) Cerebrospinal fluids. Lumbar punctures were performed only for diagnostic or therapeutic reasons and patient permission was obtained to remove additional CSF. Fresh spinal fluid, -6-7 cm3, was gently centrifuged and the supernatant fluid was removed. The cell pellet was washed once with Hanks' balanced salt solution (Gibco Laboratories, Grand Island, NY) supplemented with 5% heat inactivated pooled, normal male human serum (PHS). Cells were resuspended in medium that consisted of RPMI 1640 (Gibco Laboratories), 20 mM Hepes buffer (Gibco Laboratories), 10% PHS, penicillin, and streptomycin. Cells were either used immediately or stored at 40C overnight. Cells from one CSF were frozen and kept in liquid nitrogen for 1 wk before being used.
Peripheral blood mononuclear cells (PBM). Our procedures for the isolation of peripheral blood mononuclear cells (PBM) and the fractionation of PBM into T and non-T-cell enriched populations have been described in detail (22) . Briefly, PBM were obtained from heparinized peripheral blood by centrifugation on a Ficoll-Hypaque gradient. Cells were separated into T and non-T cells using a sheep erythrocyte rosetting technique. The T and non-T cell fractions were washed and resuspended in culture medium as above. The remaining PBM and unused T and non-T cell fractions were frozen and stored at -800C or in liquid nitrogen.
Stimulation ofCSF lymphocytes. Three protocols were followed in stimulating CSF lymphocytes. In the first protocol, CSF lymphocytes were cultured for 7 d with irradiated (3,000 rad), autologous non-T cells at a responder/stimulator ratio of 1:4. In the second protocol, CSF lymphocytes were stimulated with autologous non-T cells and cultured for 14 (27) . Cells at the 40/50% interface and the 50/55% interface were collected. These cells, consisting almost entirely of large cells, were washed in Hanks' balanced salt solution with 5% PHS, and resuspended in cloning medium that consisted of culture medium as described above supplemented with an optimal concentration of Interleukin-2 (11-2). 11-2 was prepared from peripheral blood lymphocytes as described in Inouye et al. (28) .
Preparation of clones. The were either three times background cpm or were >1,000 cpm. The more rigorous criterion was always used. Since the great majority of background cpm from unstimulated clones were <300 cpm, most "positive" clones had cpm greater than four times background. In addition, standard deviations were almost always <30% and usually 10-20% 
Results
Numbers ofspinalfluid lymphocytes in MS and control subjects. (Tables I and II) . The one MS CSF from which no clones were obtained had been frozen before being cultured. A total of 275 clones were assayed from MS CSF, using the autologous and autologous (auto-auto) stimulation protocol. Representative values that were obtained from responding clones are shown in Table III .
The specificities of clones that were derived from autologously stimulated CSF are shown in Table IV 47 (13) 92 (7) 301 (39) sharing of DR antigens (Fig. 2) . A similar situation was noted with control CSF 64. The proliferative responses of CSF clones thus corresponded with shared responder/stimulator DR phenotypes in some instances. In other instances, no such correlation was observed.
Comparison ofperipheral and CSF lymphocyte responses. In two experiments, using control CSF 62 and 64, responses of peripheral blood T cells were compared with autologous CSF cells. Results are shown in Table V . These data, while limited, are in agreement with our observations on autologously stimulated peripheral and CSF lymphocytes, that lymphocyte populations within the CSF differ both quantitatively and qualitatively from those seen in peripheral blood.
Surface antigen phenotypes ofclones. 44 clones were tested for surface antigen phenotypes using the monoclonal antibodies OKT3, OKT4, and OKT8. 38 of the clones were derived from MS CSF; two were from control CSF; and four were derived from the peripheral blood of an MS patient. Table VIII lists the phenotypes of the clones as well as their patterns of reaction. All clones reacted with OKT3 antibody, which indicated that they were mature T cells. Of particular interest are the 11% of clones from MS CSF that were both OKT4+8+. It is unlikely that these represented nonclonal mixtures of cells, since each of the percentages from OKT4+ and OKT8+ were >75%, and in two instances >90%.
Discussion
We have successfully cultured and cloned lymphocytes from spinal fluids of MS and control individuals and have demon- (37) that is sometimes associated with multifocal CNS dysfunction, we could not conclusively diagnose MS in this patient. In any case, the immunological responses that were noted in these CSF suggest that patients with postviral demyelination or multifocal white matter dysfunction that is perhaps related to autoimmune disease may have changes in lymphocyte populations in their CNS that are similar to those seen in MS.
The role of autologously reactive cells in MS CSF is not known. Cells responding in autologous MLR have been shown to possess both helper (20) and suppressor (21) cell function. Autologous recognition is increased in MS patients (22) , and this may result in alterations of regulatory lymphocyte subsets. Several laboratories, using both functional and monoclonal antibody assays, have demonstrated a fall in suppressor cells in both peripheral blood (38, 39) and CSF (1 1) The rationale for using allogeneic reactivity as a means of identifying cells responsive to altered self antigens is well supported by observations in both mouse (23, 24) and man (25) , which demonstrated crossreactivity between altered-self antigens and alloantigens. Our 
